Answers are grounded in this paper and cite their sources.
This cross-sectional study analyzes prescription fills, out-of-pocket costs, and carbon dioxide (CO 2 ) emissions for inhaler devices by type, therapeutic class, and specific products by payer type in the US.
No takes yet. Share an insight, caveat, or question.
Qato et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: